Giant cell myocarditis (GCM) is a form of fulminant myocarditis that is rapidly progressive and frequently lethal even in children. Over the course of 20 years, a definitive histopathologic diagnosis of GCM has been made at our institution in only two pediatric patients, and in neither instance was the diagnosis of GCM rendered on initial cardiac biopsy. We present the two patients and highlight the similarities in their clinical presentation and their challenging and inconclusive- albeit histologically similar- initial cardiac biopsy findings.
GursuHACetinIIAzakE, et al. The assessment of treatment outcomes in patients with acute viral myocarditis by speckle tracking and tissue Doppler methods.Echocardiography. 2019;36(9):1666–1674.
5.
LaufsHNigrovicPASchneiderLC, et al. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency.Mayo Clin Proc. 2002;77(1):92–96.
KociolRDCooperLTFangJC, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association.Circulation. 2020;141(6):e69–e92.
8.
VaideeswarPCooperLT.Giant cell myocarditis: clinical and pathological disease characteristics in an Indian population.Cardiovasc Pathol. 2013;22(1):70–74.
9.
CooperLTJrElAmmC.Giant cell myocarditis. Diagnosis and treatment.Herz. 2012;37(6):632–636.
10.
OkuraYDecGWHareJM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41(2):322–328.
11.
CooperLTBerryGJShabetaiR.Idiopathic giant-cell myocarditis: natural history and treatment. N Engl J Med. 1997;336(26):1860–1866.
12.
StegerCMHöferDAntretterH.Giant cell and granulomatous myocarditis necessitating cardiac transplantation: clinical, gross, and histopathological findings. Eur Surg. 2014;46(5):209–215.
13.
XuJBrooksEG.Giant cell myocarditis: a brief review.Arch Pathol Lab Med. 2016;140(12):1429–1434.
14.
KandolinRLehtonenJSalmenkiviKRäisänen-SokolowskiALommiJKupariM.Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.Circ Heart Fail. 2013;6(1):15–22.
15.
ShieldsRCTazelaarHDBerryGJCooperLTJr.The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis.J Card Fail. 2002;8(2):74–78.
16.
BlauwetLACooperLT.Idiopathic giant cell myocarditis and cardiac sarcoidosis.Heart Fail Rev. 2013;18(6):733–746.
17.
VillaANotarangeloLDRoifmanCM.Omenn syndrome: inflammation in leaky severe combined immunodeficiency.J Allergy Clin Immunol. 2008;122(6):1082–1086
18.
Arbustini E, Narula N, Giuliani L, Di Toro A. Genetic Basis of Myocarditis: Myth or Reality?. Myocarditis. 2020; 45–89.
19.
ZagoCAJacobCMde Albuquerque DinizEM, et al. Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias.Hum Immunol. 2014;75(7):662–666.
20.
BrückmannCLindnerWRoosR, et al. Severe pulmonary vascular occlusive disease following bone marrow transplantation in Omenn syndrome.Eur J Pediatr. 1991;150(4):242–245.
21.
NavabiBUptonJE.Primary immunodeficiencies associated with eosinophilia.Allergy Asthma Clin Immunol. 2016;12:27.
22.
Bracamonte-BaranWČihákováD.Cardiac autoimmunity: myocarditis. Adv Exp Med Biol. 2017;1003:187–221.
23.
EkströmKLehtonenJKandolinRRäisänen-SokolowskiASalmenkiviKKupariM.Long-term outcome and its predictors in giant cell myocarditis.Eur J Heart Fail. 2016;18(12):1452–1458.
24.
OngSLigonsDLBarinJG, et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.Am J Pathol. 2015;185(3):847–861.
25.
TschöpeCAmmiratiEBozkurtB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169–193.
26.
LitovskySHBurkeAPVirmaniR.Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. Mod Pathol. 1996;9(12):1126–1134.
